The recent challenges in global distribution have highlighted the importance of securing critical medications like Ivermectin. Relying on overseas manufacturers exposes regions to significant vulnerabilities, including shipping delays, price fluctuations, and even geopolitical risks. Shifting towards domestic procurement of Ivermectin offers a mult